Shopping Cart
- Remove All
Your shopping cart is currently empty
UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $43 | In Stock | |
| 5 mg | $107 | In Stock | |
| 10 mg | $167 | In Stock | |
| 25 mg | $338 | In Stock | |
| 50 mg | $476 | In Stock | |
| 100 mg | $678 | In Stock | |
| 200 mg | $913 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $131 | In Stock |
| Description | UTL-5g (3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl-) is a novel potential chemoprotective agent, TNF-α inhibitor that reduces cisplatin-induced side effects including nephrotoxicity, hepatotoxicity and hematotoxicity. It lowers elevated levels of AST, ALT, creatinine, BUN, and TNF-α, increases the reduced platelet count in mice, and acts as a novel chemo- and radioprotective agent. |
| In vivo | UTL-5g (GBL-5g) reduces elevated TGF-β and TNF-α levels resulting from lung irradiation[1]. |
| Synonyms | GBL-5g, 3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl- |
| Molecular Weight | 271.1 |
| Formula | C11H8Cl2N2O2 |
| Cas No. | 646530-37-2 |
| Smiles | Cc1cc(no1)C(=O)Nc1ccc(Cl)cc1Cl |
| Relative Density. | 1.469 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 27.5 mg/mL (101.44 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.